Compare GORO & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GORO | YI |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Precious Metals | Retail-Drug Stores and Proprietary Stores |
| Sector | Basic Materials | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.3M | 38.1M |
| IPO Year | N/A | N/A |
| Metric | GORO | YI |
|---|---|---|
| Price | $0.82 | $3.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.38 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 11.3K |
| Earning Date | 11-04-2025 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $61,430,000.00 | ★ $1,979,883,442.00 |
| Revenue This Year | $8.76 | N/A |
| Revenue Next Year | $85.95 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $3.19 |
| 52 Week High | $1.18 | $11.35 |
| Indicator | GORO | YI |
|---|---|---|
| Relative Strength Index (RSI) | 59.91 | 38.01 |
| Support Level | $0.72 | $3.60 |
| Resistance Level | $0.80 | $3.95 |
| Average True Range (ATR) | 0.05 | 0.22 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 96.00 | 51.22 |
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.